Concepedia

Brent N. Rexer

BN

Statistics

Publications

27

Citations

1.6K

H-Index

20

Active since

1997

Affiliations

Vanderbilt University(Current)

Dana-Farber Cancer Institute

Vanderbilt University Medical Center

Baylor College of Medicine

Johns Hopkins University

Brent N. Rexer is an author at Vanderbilt University specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

1997–2023

27

Publications

27

HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade

Aleix Prat, Tomás Pascual, Carmine De Angelis et al. · JNCI Journal of the National Cancer Institute · 2019 · 169 citations · Full text

, , +17

Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition

Brent N. Rexer, Cammie Rinehart, Salisha Hill et al. · Oncogene · 2011 · 139 citations · Full text

, , +16

H1047R phosphatidylinositol 3-kinase mutant enhances HER2-mediated transformation by heregulin production and activation of HER3

Anindita Chakrabarty, Brent N. Rexer, S E Wang et al. · Oncogene · 2010 · 101 citations · Full text

, , +11

Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer

Ariella B. Hanker, Mónica V. Estrada, Giampaolo Bianchini et al. · Cancer Research · 2017 · 100 citations

, , +17

Optical imaging of metabolism in HER2 overexpressing breast cancer cells

Alex J. Walsh, Rebecca S. Cook, Brent N. Rexer et al. · Biomedical Optics Express · 2011 · 86 citations · Full text

, , +17

1–5 of 27